Self-emulsifying agglomerant of oral polypeptide medicine

A polypeptide and self-emulsification technology, which is applied in the fields of pharmaceutical formulation, emulsion delivery, peptide/protein composition, etc., can solve the problems of bioavailability not exceeding 5%, unsatisfactory results, etc.
CN1456351AInactive Publication Date: 2003-11-19SHANGHAI INST OF PHARMA IND

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
SHANGHAI INST OF PHARMA IND
Publication Date
2003-11-19
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

An oral-applied self-emulsifying polypeptide medicine is prepared from polypeptide, gel adhesive, surfactant, co-surfactant, oil enzyme inhibitor, and diluent. Its preparing process is also disclosed. It features that after it comes in intestinal tract, it is emulsified by itself to become nano-class microemulsion, which can penetrate through intestinal mucosa and epithelial barrier into lymph and blood, and be attached on intestinal inner surface to promote its absorption.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to an oral polypeptide drug preparation and a preparation method thereof. Background technique

[0002] With the development of biotechnology and genetic engineering, more and more polypeptide and protein drugs are used in clinical treatment, and most polypeptide drugs are biologically active and unstable to heat and enzymes, so they are often given by injection. medicine. However, long-term injection administration brings great pain to patients, and requires special injection techniques, which makes it difficult for patients to administer medicines independently, resulting in high finished products and high medical expenses. Therefore, domestic and foreign pharmaceutical workers have been committed to the research of non-injection routes of polypeptide drugs, such as nasal cavity, rectal, oral, lung, eye, transdermal absorption and so on. Among the above-mentioned routes of administration, oral administration is particularly at...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More